If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
283.00    0.00 (0.00%)
Bid:
274.00
Ask:
280.00
Spread: 6.00 (2.19%)
Market Cap: £253.44m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

AGM Statement and Q1 Trading Update

1 Nov 2018 07:00

RNS Number : 9329F
Wilmington PLC
01 November 2018
 

1 November 2018 

 

Wilmington plc

('Wilmington', 'the Group' or 'the Company')

AGM Statement and Q1 Trading Update

 

Wilmington plc, the provider of information, education and networking services in Risk & Compliance, Healthcare and Professional knowledge areas, today announces a trading update for the three month period to 30 September 2018. This statement is being made ahead of its Annual General Meeting that is taking place later today.

 

Trading Update

 

In what is traditionally the quietest trading period for the Group, revenue performance in the first quarter has been reasonable, with a mix of performances across the different divisions. Overall revenue reduced 1% on an organic basis (i.e. at constant currencies and after adjusting for acquisitions and disposals) compared to the same period last year. This compares to the 3% organic revenue decline experienced across the prior year.

 

On a divisional basis, revenue in the Risk & Compliance division was up 7% organically, with good momentum in the main Compliance business, partly as a result of favourable timing issues that accelerated revenue from Q2 into the first three months this year. In the Healthcare division revenue declined 7% on an organic basis reflecting the reduction in deferred revenue noted in September's full year results announcement, as well as the continued impact of the decision to reduce US networking events to focus on improving profitability. Importantly from the perspective of future revenue progression in Healthcare, new business sales in the first quarter in the UK Healthcare business were up over 2% year on year and early indications for Q2 are that sales are expected to be further up compared to weak comparatives in the prior year. Revenue in the Professional businesses was flat year on year, excluding the impact of Ark, the legal services business that was closed in the first half of last year. 

 

Profit in the period, as anticipated, was down year on year due to the previously disclosed cost increases and investments made last year. This position was exacerbated slightly by a weaker than expected product mix in Q1 although this is expected to be a timing issue that will reverse over the course of the full year.

 

Net debt at 30 September 2018 was £44.4m (30 June 2018: £39.6m; 30 September 2017: £42.4m). The outflow since the start of the year is a function of usual seasonal outflows, and the final earn-out payment for SWAT which was acquired in July 2016.

 

Outlook

 

There is no change in anticipated trading outlook since the full year 2018 results announcement on 12 September 2018. The overall outcome from the divisional revenue and sales performance in the first quarter gives some early encouragement that momentum across the Group is starting to shift as required to achieve full year revenue and profit expectations. Whilst uncertainties remain within the macro economic environment, the changes in regulations that will come into force in the UK as a result of Brexit are likely to lead to new business opportunities in the second half of the year which will help to underpin our growth plans.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement this inside information is now considered to be in the public domain.

For further information, please contact:

Wilmington plc

Pedro Ros, Chief Executive Officer

Richard Amos, Chief Financial Officer

 

FTI Consulting

Charles Palmer / Dwight Burden / Leah Dudley

020 7422 6800

 

 

 

020 3727 1000

 

 

Notes to Editors

Wilmington plc is the recognised knowledge leader and partner of choice for information, education and networking in Risk & Compliance, Healthcare and Professional areas. Wilmington employs close to 1,000 people and has customers in 120 countries. Wilmington plc is a premium listed company on the main market of the London Stock Exchange.

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAKEFDLLPFFF
Date   Source Headline
25th May 20101:32 pmRNSDirector/PDMR Shareholding
24th May 20102:41 pmRNSDirector/PDMR Shareholding
17th May 20107:00 amRNSInterim Management Statement
5th May 20109:29 amRNSBlocklisting Interim Review
4th May 201010:41 amRNSTotal Voting Rights
6th Apr 201010:29 amRNSTotal Voting Rights
18th Mar 20104:34 pmRNSDirector/PDMR Shareholding
18th Mar 20103:16 pmRNSHolding(s) in Company
16th Mar 20102:26 pmRNSHolding(s) in Company
3rd Mar 20103:45 pmRNSTotal Voting Rights
25th Feb 20104:49 pmRNSHolding(s) in Company
25th Feb 20103:08 pmRNSHolding(s) in Company
25th Feb 20107:00 amRNSHalf Yearly Report
1st Feb 201010:44 amRNSTotal Voting Rights
12th Jan 20104:35 pmRNSPrice Monitoring Extension
4th Jan 20103:31 pmRNSTotal Voting Rights
3rd Dec 20095:06 pmRNSAnnual Information Update
1st Dec 20092:49 pmRNSTotal Voting Rights
12th Nov 200911:52 amRNSResult of AGM
11th Nov 20097:00 amRNSInterim Management Statement
4th Nov 200911:22 amRNSBlocklisting Review
3rd Nov 200911:40 amRNSTotal Voting Rights
15th Oct 200911:18 amRNSDirector/PDMR Shareholding
14th Oct 200912:31 pmRNSDirector/PDMR Shareholding
5th Oct 200911:25 amRNSTotal Voting Rights
23rd Sep 20094:14 pmRNSDirector/PDMR Shareholding
17th Sep 20097:00 amRNSFinal Results
2nd Sep 200911:17 amRNSTotal Voting Rights
2nd Sep 20099:30 amRNSNotice of Results
6th Aug 20094:41 pmRNSSecond Price Monitoring Extn
6th Aug 20094:35 pmRNSPrice Monitoring Extension
3rd Aug 200910:07 amRNSTotal Voting Rights
9th Jul 20097:00 amRNSTrading Update
1st Jul 200911:08 amRNSTotal Voting Rights
1st Jun 200911:29 amRNSTotal Voting Rights
14th May 20097:00 amRNSInterim Management Statement
1st May 200912:39 pmRNSTotal Voting Rights
24th Apr 20094:40 pmRNSSecond Price Monitoring Extn
24th Apr 20094:36 pmRNSPrice Monitoring Extension
20th Apr 20094:40 pmRNSSecond Price Monitoring Extn
20th Apr 20094:35 pmRNSPrice Monitoring Extension
8th Apr 200912:14 pmRNSDirector/PDMR Shareholding
1st Apr 200911:27 amRNSTotal Voting Rights
12th Mar 20093:44 pmRNSDirector/PDMR Shareholding
2nd Mar 20092:49 pmRNSVoting Rights and Capital
27th Feb 20092:27 pmRNSDirector/PDMR Shareholding
27th Feb 20092:25 pmRNSDirector/PDMR Shareholding
26th Feb 20097:00 amRNSInterim Results
3rd Feb 20095:26 pmRNSTotal Voting Rights
16th Jan 20094:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.